﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>pharma news stories on Newser</title><description>Read more pharma stories on Newser</description><link>http://www.newser.com/taggrid/2221/pharma.html</link><copyright>2009 - Newser</copyright><language>en-us</language><generator>Newser Feed Generator</generator><pubDate>Tue, 24 Nov 2009 8:20:23 CST</pubDate><item><guid isPermaLink="true">http://www.newser.com/story/71879/dems-helped-shape-health-industry-ad-campaign.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Dems Helped Shape Health Industry Ad Campaign</title><description>Aides to President Obama and Max Baucus met with a variety of lobbyists for corporate health care companies on April 15, to help form two industry coalitions and launch a multimillion-dollar ad campaign, Politico has learned. Though both sides insist no quid pro quo was laid out, some participants say...</description><link>http://www.newser.com/story/71879/dems-helped-shape-health-industry-ad-campaign.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Fri, 16 Oct 2009 11:19:01 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/66132/pharma-ghostwriters-penned-medical-papers-on-hrt.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Pharma Ghostwriters Penned Medical Papers on HRT</title><description>Ghostwriters funded by a drug firm were deeply involved in writing papers supporting therapies that helped the firm’s sales boom, court papers show. The 26 scientific papers, published in medical journals from 1998 to 2005, highlighted the benefits of hormone replacement therapy over the risks, a boon to Wyeth, which...</description><link>http://www.newser.com/story/66132/pharma-ghostwriters-penned-medical-papers-on-hrt.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Wed, 05 Aug 2009 7:20:00 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/62404/obama-big-pharma-heres-an-80b-drug-discount.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Obama? Big Pharma. Here's an $80B Drug Discount</title><description>Big Pharma has offered the feds a discount of up to $80 billion on drugs for programs like Medicare, the Washington Post reports. The pledge, which comes at a crucial moment in the health-reform debate, may be a pre-emptive strike before President Obama pushes for a proposed $100 billion price...</description><link>http://www.newser.com/story/62404/obama-big-pharma-heres-an-80b-drug-discount.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Sat, 20 Jun 2009 16:41:06 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/30348/big-pharma-sickens-universities.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Big Pharma Sickens Universities</title><description>Weak legislation allows professors to collect huge under-the-table payments from Big Pharma, and it’s time to fight back, Dan Greenberg writes in the Chronicle of Higher Education . Pharmaceutical companies pay professors to shill drugs and lend their names to industry research, and the only oversight is an honor-system mechanism requiring...</description><link>http://www.newser.com/story/30348/big-pharma-sickens-universities.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Sun, 22 Jun 2008 18:07:27 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/5508/generics-curb-rise-in-drug-costs.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Generics Curb Rise in Drug Costs</title><description>Scores of prescription drugs are getting cheaper, as name-brand patents expire and open the door to generic imitators. That's bad news for pharmaceutical companies, the Times reports, but it means that an aging population ever more reliant on drugs will be paying as much as 80 percent less for them.</description><link>http://www.newser.com/story/5508/generics-curb-rise-in-drug-costs.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Wed, 08 Aug 2007 18:37:49 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/5377/grocery-chain-offers-free-rx-meds.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Grocery Chain Offers Free Rx Meds</title><description>Pharmacies in Publix supermarkets across five Southern states will distribute seven antibiotics free to patients with prescriptions, the chain said today. The CEO allows that one goal is to drive customer traffic, but it's also an example of the private sector assisting access to affordable health care, the AP reports....</description><link>http://www.newser.com/story/5377/grocery-chain-offers-free-rx-meds.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Mon, 06 Aug 2007 15:17:09 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/2831/nigeria-sues-pfizer-over-deadly-tests.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Nigeria Sues Pfizer Over Deadly Tests</title><description>Nigeria is suing pharma giant Pfizer for $7 billion, claiming the company carried out improper trials on children. 200 children in the state of Kano died, and others developed deformities, after Pfizer tested Trovan, an experimental antibiotic, during a 1996 meningitis outbreak. Nigeria claims the tests were unauthorized, but Pfizer...</description><link>http://www.newser.com/story/2831/nigeria-sues-pfizer-over-deadly-tests.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Tue, 05 Jun 2007 12:35:06 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/2676/glaxo-stems-stock-slide-over-avandia.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Glaxo Stems Stock Slide Over Avandia</title><description>Glaxo shares pulled out of a tailspin after the pharma giant defended its second biggest selling drug, Avandia, against claims that it triggers heart attacks. A sharply worded letter from the company's chief medical officer on the website of medical journal The Lancet pointed out that the increased incidence of...</description><link>http://www.newser.com/story/2676/glaxo-stems-stock-slide-over-avandia.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Thu, 31 May 2007 6:44:02 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/2482/fda-warned-of-avandia-risks-years-ago.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>FDA Warned of Avandia Risks Years Ago</title><description>A diabetes doctor warned the FDA of heart risks posed by the diabetes drug Avandia seven years ago, the New York Times reports. The same concerns raised by Dr. John Buse in a 2000 letter were reiterated in a study published by cardiologist Steven Nissen this week.</description><link>http://www.newser.com/story/2482/fda-warned-of-avandia-risks-years-ago.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Thu, 24 May 2007 13:56:03 CDT</pubDate></item></channel></rss>